(sda) So far, the vaccine was approved for children from the age of twelve. The lowering of the age limit was preceded by a recommendation from a panel of experts.
In the US, the Biontech vaccine has been approved for ages five and up since the beginning of the month. The companies have also applied for approval of their vaccine for five to eleven year olds in the EU. The European Medicines Agency (EMA) is expected to make a decision before Christmas.
The Biontech vaccine is administered to five to eleven year olds in two vaccinations with a dose of ten micrograms each. That is a third of the usual adult dosage. According to Pfizer, the protection against Covid 19 disease by vaccination in this age group is 90.7 percent.
–
